AllExam Dumps

DUMPS, FREE DUMPS, VCP5 DUMPS| VMWARE DUMPS, VCP DUMPS, VCP4 DUMPS, VCAP DUMPS, VCDX DUMPS, CISCO DUMPS, CCNA, CCNA DUMPS, CCNP DUMPS, CCIE DUMPS, ITIL, EXIN DUMPS,


READ Free Dumps For AHIP- AHM-540





Question ID 21650

The Glenway Health Plans pharmacy and therapeutics (P&T) committee conducted
pharmacoeconomic research to measure both the clinical outcomes and costs of two new
cholesterol-reducing drugs. Results were presented as a ratio showing the cost required to
produce a 1 mcg/l decrease in cholesterol levels. The type of pharmacoeconomic research
that Glenway conducted in this situation was most likely

Option A

 cost-effectiveness analysis (CEA)

Option B

cost-minimization analysis (CMA)

Option C

cost-utility analysis (CUA)

Option D

cost of illness analysis (COI)

Correct Answer A
Explanation


Question ID 21651

Helena Ray, a member of the Harbrace Health Plan, suffers from migraine headaches. To
treat Ms. Rays condition, her physician has prescribed Upzil, a medication that has Food
and Drug Administration (FDA) approval only for the treatment of depression. Upzil has not
been tested for safety or effectiveness in the treatment of migraine headache. Although
Harbraces medical policy for migraine headache does not include coverage of Upzil,
Harbrace has agreed to provide extra-contractual coverage of Upzil for Ms. Ray.
The following statement(s) can correctly be made about Harbraces use of extra-
contractual coverage:
1.Harbraces medical policy most likely establishes the procedure that Harbrace used to
evaluate the value of Upzil for treating Ms. Ray
2.One way for Harbrace to reduce the risk associated with extra-contractual coverage is by
including an alternative care provision in its contracts with purchasers

Option A

Both 1 and 2

Option B

 1 only

Option C

 2 only

Option D

Neither 1 nor 2

Correct Answer C
Explanation

Send email to admin@getfreedumps for new dumps request!!!